Diana Huang | Investor Relations, Manager |
Zhilin Li | President and Chief Executive Officer and Interim Chief Financial Officer |
Sam Hsing | Corporate Vice President |
Ladies and gentlemen, thank you standing by and welcome to China Pharma Holdings Inc. Q1 2019 Earnings Conference Call. At this time, all participants are in listen-only mode. There will be a presentation followed by question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your first speaker today, Ms.